The contributing role of CD14 in toll-like receptor 4 dependent neuropathic pain

Neuroscience

Volumn 158, Issue 2, 2009, Pages 896-903

  Cao, L ^a   Tanga, F Y ^a   DeLeo, J A ^a,b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

mechanical allodynia and thermal hyperalgesia; spinal nerve transection; TLR4

Indexed keywords

CD14 ANTIGEN; TOLL LIKE RECEPTOR 4;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; HEAT SENSITIVITY; HYPERALGESIA; LUMBAR SPINAL CORD; MALE; MECHANICAL STIMULATION; MICROGLIA; MOUSE; NERVE TRANSECTION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD14; AXOTOMY; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MUTATION; NEURALGIA; PAIN MEASUREMENT; PAIN THRESHOLD; REACTION TIME; SPINAL CORD; SPINAL NERVES; TOLL-LIKE RECEPTOR 4;

EID: 58249083141     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.10.004     Document Type: Article

References (38)

1. Abbadie C., Lindia J.A., Cumiskey A.M., Peterson L.B., Mudgett J.S., Bayne E.K., DeMartino J.A., MacIntyre D.E., and Forrest M.J. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci U S A 100 (2003) 7947-7952
2. Aravalli R.N., Peterson P.K., and Lokensgard J.R. Toll-like receptors in defense and damage of the central nervous system. J Neuroimmune Pharmacol 2 (2007) 297-312
3. Bas S., Gauthier B.R., Spenato U., Stingelin S., and Gabay C. CD14 is an acute-phase protein. J Immunol 172 (2004) 4470-4479
4. Bettoni I., et al. Glial TLR4 receptor as new target to treat neuropathic pain: Efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia 56 (2008) 1312-1319
5. Cao L., and DeLeo J.A. CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain. Eur J Immunol 38 (2008) 448-458
6. Cauwels A., Frei K., Sansano S., Fearns C., Ulevitch R., Zimmerli W., and Landmann R. The origin and function of soluble CD14 in experimental bacterial meningitis. J Immunol 162 (1999) 4762-4772
7. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53 (1994) 55-63
8. Chessell I.P., Hatcher J.P., Bountra C., Michel A.D., Hughes J.P., Green P., Egerton J., Murfin M., Richardson J., Peck W.L., Grahames C.B., Casula M.A., Yiangou Y., Birch R., Anand P., and Buell G.N. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114 (2005) 386-396
9. DeLeo J.A., and Yezierski R.P. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90 (2001) 1-6
10. Fassbender K., Walter S., Kuhl S., Landmann R., Ishii K., Bertsch T., Stalder A.K., Muehlhauser F., Liu Y., Ulmer A.J., Rivest S., Lentschat A., Gulbins E., Jucker M., Staufenbiel M., Brechtel K., Walter J., Multhaup G., Penke B., Adachi Y., Hartmann T., and Beyreuther K. The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J 18 (2004) 203-205
11. Hanisch U.K., and Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10 (2007) 1387-1394
12. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
13. Haziot A., Ferrero E., Kontgen F., Hijiya N., Yamamoto S., Silver J., Stewart C.L., and Goyert S.M. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4 (1996) 407-414
14. Hylden J.L., and Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67 (1980) 313-316
15. Kakimura J.-I., Kitamura Y., Takata K., Umeki M., Suzuki S., Shibagaki K., Taniguchi T., Nomura Y., Gebicke-Haerter P.J., Smith M.A., Perry G., and Shimohama S. Microglial activation and amyloid-{beta} clearance induced by exogenous heat-shock proteins. FASEB J 16 (2002) 601-603
16. Kim D., Kim M.A., Cho I.H., Kim M.S., Lee S., Jo E.K., Choi S.Y., Park K., Kim J.S., Akira S., Na H.S., Oh S.B., and Lee S.J. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem 282 (2007) 14975-14983
17. Kol A., Lichtman A.H., Finberg R.W., Libby P., and Kurt-Jones E.A. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol 164 (2000) 13-17
18. Krishnan J., Selvarajoo K., Tsuchiya M., Lee G., and Choi S. Toll-like receptor signal transduction. Exp Mol Med 39 (2007) 421-438
19. Lacroix-Fralish M.L., Tawfik V.L., Nutile-McMenemy N., and DeLeo J.A. Progesterone mediates gonadal hormone differences in tactile and thermal hypersensitivity following L5 nerve root ligation in female rats. Neuroscience 138 (2006) 601-608
20. Lacroix-Fralish M.L., Tawfik V.L., Nutile-McMenemy N., Harris B.T., and Deleo J.A. Differential regulation of neuregulin 1 expression by progesterone in astrocytes and neurons. Neuron Glia Biol 2 (2006) 227-234
21. Landmann R., Muller B., and Zimmerli W. CD14, new aspects of ligand and signal diversity. Microbes Infect 2 (2000) 295-304
22. Lutterotti A., Kuenz B., Gredler V., Khalil M., Ehling R., Gneiss C., Egg R., Deisenhammer F., Berger T., and Reindl M. Increased serum levels of soluble CD14 indicate stable multiple sclerosis. J Neuroimmunol 181 (2006) 145-149
23. Milligan E., Zapata V., Schoeniger D., Chacur M., Green P., Poole S., Martin D., Maier S.F., and Watkins L.R. An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine. Eur J Neurosci 22 (2005) 2775-2782
24. Miyake K. Innate recognition of lipopolysaccharide by toll-like receptor 4-MD-2. Trends Microbiol 12 (2004) 186-192
25. Miyake K. Innate immune sensing of pathogens and danger signals by cell surface toll-like receptors. Semin Immunol 19 (2007) 3-10
26. Muzio L., Martino G., and Furlan R. Multifaceted aspects of inflammation in multiple sclerosis: The role of microglia. J Neuroimmunol 191 (2007) 39-44
27. Poltorak A., He X., Smirnova I., Liu M.-Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282 (1998) 2085-2088
28. Ponomarev E.D., Shriver L.P., Maresz K., and Dittel B.N. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res 81 (2005) 374-389
29. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav Immun 17 (2003) 13-19
30. Stence N., Waite M., and Dailey M.E. Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices. Glia 33 (2001) 256-266
31. Stenzel W., Soltek S., Sanchez-Ruiz M., Akira S., Miletic H., Schluter D., and Deckert M. Both TLR2 and TLR4 are required for the effective immune response in Staphylococcus aureus-induced experimental murine brain abscess. Am J Pathol 172 (2008) 132-145
32. Tahara K., Kim H.D., Jin J.J., Maxwell J.A., Li L., and Fukuchi K. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 129 (2006) 3006-3019
33. Tanga F.Y., Nutile-McMenemy N., and DeLeo J.A. The CNS role of toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A 102 (2005) 5856-5861
34. Tanga F.Y., Raghavendra V., and DeLeo J.A. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem Int 45 (2004) 397-407
35. Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M.W., and Inoue K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424 (2003) 778-783
36. Watkins L.R., Milligan E.D., and Maier S.F. Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol 521 (2003) 1-21
37. Wieseler-Frank J., Maier S.F., and Watkins L.R. Central proinflammatory cytokines and pain enhancement. Neurosignals 14 (2005) 166-174
38. Wyss-Coray T., and Mucke L. Inflammation in neurodegenerative disease: a double-edged sword. Neuron 35 (2002) 419-432